anti-BCL2-Like 2 (BCL2L2) Antikörper

BCL2L2 encodes a member of the BCL-2 protein family. Zusätzlich bieten wir Ihnen BCL2-Like 2 Proteine (18) und BCL2-Like 2 Kits (11) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
BCL2L2 599 Q92843
BCL2L2 12050 P70345
BCL2L2 60434  
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen

Top anti-BCL2-Like 2 Antikörper auf

Showing 10 out of 124 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Rind (Kuh) Kaninchen Unkonjugiert WB WB Suggested Anti-Bcl2l2 AntibodyTitration: 1.0 µg/mL <br /> Positive Control: Mouse Testis 100 μL Anmelden zum Anzeigen 2 bis 3 Tage
Human Kaninchen Unkonjugiert IHC (p), WB Western blot analysis of anti-Bcl-w BH3 domain Pab (ABIN388097) in HL-60 cell lysate. Bcl-w BH3 domain (arrow) was detected using purified polyclonal antibody. Secondary HRP-anti-rabbit was used for signal visualization with chemiluminescence. Western blot analysis of Bcl-w3 (arrow) using rabbit polyclonal Bcl-w BH3 Domain Antibody (ABIN388097). 293 cell lysates (2 µg/lane) either nontransfected (Lane 1) or transiently transfected with the BCL2L2 gene (Lane 2) (Origene Technologies). 400 μL Anmelden zum Anzeigen 10 bis 11 Tage
Rind (Kuh) Kaninchen Unkonjugiert IC, IF, IHC, WB Immunofluorescent analysis of BCLW staining in HL60 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue). Immunohistochemical analysis of BCLW staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. 200 μL Anmelden zum Anzeigen 13 bis 14 Tage
Human Kaninchen Unkonjugiert IF, ELISA, WB Western blot analysis of extracts from COLO cells, using BCLW Antibody. The lane on the right is treated with the synthesized peptide. Immunofluorescence analysis of HepG2 cells, using BCLW Antibody. The picture on the right is treated with the synthesized peptide. 100 μg Anmelden zum Anzeigen 2 bis 3 Tage
Human Ratte Unkonjugiert WB Western blot analysis for Bcl-w. Lysates from mouse brain tissue were probed with the rat anti- Bcl-w antibody at concentrations of 0.5 µg/mL (lane 1), 0.25 µg/mL (lane 2), and 0.125 µg/mL (lane 3). Bcl-w may be observed to be migrating in a range from 21-25 kDa. 50 μg Anmelden zum Anzeigen 6 bis 8 Tage
Human Kaninchen Unkonjugiert EIA, IHC (p), WB   0.1 mg Anmelden zum Anzeigen 12 bis 15 Tage
Human Kaninchen Unkonjugiert IHC (p), WB Anti- BCL2L2 antibody, IHC(P) IHC(P): Human Rectal Cancer Tissue Anti- BCL2L2 antibody,  Western blotting All lanes: Anti BCL2L2 () at 0.5ug/ml WB: HELAWhole Cell Lysate at 40ug Predicted bind size: 21KD Observed bind size: 21KD 100 μg Anmelden zum Anzeigen 4 bis 6 Tage
Human Kaninchen Unkonjugiert IHC, WB 100 μL Anmelden zum Anzeigen 16 Days
Human Kaninchen Unkonjugiert ICC, IF, IHC, WB Western Blot: BCL-W/BCL2L2 Antibody [NBP1-19705] - Analysis of Bcl-w (G154) antibody in extracts from COLO cells. 0.1 mL Anmelden zum Anzeigen 7 bis 9 Tage
Human Kaninchen Unkonjugiert ICC, IHC, IP, WB Figure.DAB staining on IHC-P. Samples: Human Tissue 100 μg Anmelden zum Anzeigen 13 bis 16 Tage

BCL2L2 Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität Konjugat
Human , , , ,
, , ,
, , , , , , , , , , , , , , , , ,
Mouse (Murine) , , ,
, , ,
, , , , , , , , , , , , , , , ,
Rat (Rattus) , ,
, ,
, , , , , , , , , , , , ,

Am meisten referenzierte anti-BCL2-Like 2 Antikörper

  1. Human Monoclonal BCL2L2 Primary Antibody für WB - ABIN967292 : Adams, Cory: The Bcl-2 protein family: arbiters of cell survival. in Science (New York, N.Y.) 1998 (PubMed)
    Show all 5 Pubmed References

Weitere Antikörper gegen BCL2-Like 2 Interaktionspartner

Human BCL2-Like 2 (BCL2L2) Interaktionspartner

  1. BCL-W contributes to the threshold of anti-apoptotic activity during mitosis

  2. we demonstrated that miR (zeige MLXIP Antikörper)-126-5p plays an inhibitory role in human cervical cancer progression, regulating the apoptosis of cancer cells via directly targeting Bcl2l2.

  3. High expression of Bcl-w was associated with mesenchymal changes and invading populations in the glioblastoma multiforme; Bcl-w functions as a positive regulator of invasion by enhancing mesenchymal traits of glioblastoma multiforme, consequently contributing to malignancy.

  4. BCL2L2 was the virtual target of miR (zeige MLXIP Antikörper)-133b, and we found a negative regulatory relationship between miR (zeige MLXIP Antikörper)-133b and BCL2L2. MiR (zeige MLXIP Antikörper)-133b and BCL2L2 interfered with the viability and apoptosis of cells.

  5. overexpression of miR (zeige MLXIP Antikörper)-15a in the FaDu cells was associated with significantly decreased BCL2L2 and BCL2 (zeige BCL2 Antikörper) expression and a significant increase in the apoptosis rate. The opposite results were observed in HPV-positive HSCC, where downregulation of miR (zeige MLXIP Antikörper)-15a suppressed apoptosis

  6. we conclude that BER treatment reduces cisplatin resistance of gastric cancer cells by modulating the miR (zeige MLXIP Antikörper)-203/Bcl-w apoptotic axis. BER may be a novel agent to enhance chemotherapeutic responses in cisplatin-resistant gastric cancer patients

  7. Genetic and pharmacological inhibition of BCL-W and BCL-XL (zeige BCL2L1 Antikörper) causes directed elimination of senescent cells.

  8. Data show that BCL2-like 2 protein (BCL2L2) is a direct target of micrRNA miR (zeige MLXIP Antikörper)-29b.

  9. these results indicate that miR (zeige MLXIP Antikörper)-335 acts as a novel tumor suppressor to regulate ccRCC cell proliferation and invasion through downregulation of BCL-W expression.

  10. miR (zeige MLXIP Antikörper)-15a acts as a tumor suppressor in NSCLC by directly targeting BCL2L2 and may serve as a potential diagnostic biomarker and therapeutic target for NSCLC.

Mouse (Murine) BCL2-Like 2 (BCL2L2) Interaktionspartner

  1. Bcl2l2

  2. MYC (zeige MYC Antikörper) regulates BCL-W expression through its transcriptional regulation of specific miR (zeige MLXIP Antikörper).

  3. Genetic and pharmacological inhibition of BCL-W and BCL-XL (zeige BCL2L1 Antikörper) causes directed elimination of senescent cells.

  4. NF-kappaB (zeige NFKB1 Antikörper) p65 (zeige NFkBP65 Antikörper)/p52 (zeige GTF2H4 Antikörper) signaling mediated the effects of GDNF on Bcl-2 (zeige BCL2 Antikörper) and Bcl-w expressions

  5. Target-derived neurotrophins coordinate transcription of the antiapoptotic gene bclw with transport of bclw mRNA to the axon, and thereby prevent axonal degeneration in rat and mouse sensory neurons.

  6. By using human cancer cells and mouse embryonic fibroblasts, the study shows that Bcl-w functions in the mitochondria to increase the levels of reactive oxygen species (ROS (zeige ROS1 Antikörper)), which subsequently stimulates the invasion-promoting signaling pathway.

  7. Bcl-2 (zeige BCL2 Antikörper), Bcl-x(L (zeige BCL2L1 Antikörper)) and Bcl-w have only minor roles in thymic lymphoma development elicited by defects in p53 (zeige TP53 Antikörper), and this may indicate that Mcl-1 (zeige MCL1 Antikörper) and/or A1 may feature more prominently in this process.

  8. Induction of autocrine Bcl-w signaling through pericytes promoting endothelial cell survival is associated with melanoma development.

  9. Bcl-w(-/-) sensory neurons exhibit mitochondrial abnormalities, including alterations in axonal mitochondrial size, axonal mitochondrial membrane potential, and cellular ATP levels.

  10. Bcl-x(L) and Bcl-w target protein phosphatase 1alpha to Bad

Cow (Bovine) BCL2-Like 2 (BCL2L2) Interaktionspartner

  1. Chromosome mapping of BCL2L2 gene in cows.

BCL2-Like 2 (BCL2L2) Antigen-Profil

Protein Überblick

This gene encodes a member of the BCL-2 protein family. The proteins of this family form hetero- or homodimers and act as anti- and pro-apoptotic regulators. Expression of this gene in cells has been shown to contribute to reduced cell apoptosis under cytotoxic conditions. Studies of the related gene in mice indicated a role in the survival of NGF- and BDNF-dependent neurons. Mutation and knockout studies of the mouse gene demonstrated an essential role in adult spermatogenesis. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the neighboring downstream PABPN1 (poly(A) binding protein, nuclear 1) gene.

Genbezeichner und Symbole assoziert mit anti-BCL2-Like 2 (BCL2L2) Antikörper

  • BCL2-like 2 (bcl2l2) Antikörper
  • BCL2 like 2 (BCL2L2) Antikörper
  • BCL2-like 2 (Bcl2l2) Antikörper
  • Bcl2-like 2 (Bcl2l2) Antikörper
  • AW048834 Antikörper
  • Bcl-w Antikörper
  • BCL-WEL Antikörper
  • BCL-WS Antikörper
  • BCL2-L-2 Antikörper
  • BCL2L2 Antikörper
  • Bclw Antikörper
  • c98 Antikörper
  • Gtrgal2 Antikörper
  • Gtrosa41 Antikörper
  • PPP1R51 Antikörper

Bezeichner auf Proteinebene für anti-BCL2-Like 2 (BCL2L2) Antikörper

Bcl2-like 2 , BCL2-like 2 , apoptosis regulator BCL-W , bcl-2-like protein 2 , protein phosphatase 1, regulatory subunit 51 , apoptosis regulator Bcl-W , bcl2-L-2

496475 Xenopus (Silurana) tropicalis
768265 Felis catus
599 Homo sapiens
12050 Mus musculus
490611 Canis lupus familiaris
60434 Rattus norvegicus
767601 Bos taurus
Ausgewählte Anbieter für anti-BCL2-Like 2 (BCL2L2) Antikörper
Haben Sie etwas anderes gesucht?